Asston Pharmaceuticals IPO

BSELot: 1000

LISTEDSME
Issue Price123
Listing119
Current80
Price Band
115 - ₹123
Lot Size
1,000
Issue Size
₹27.56 Cr
GMP
0
Subscription
1.75x

IPO Schedule

1
Open
9 Jul
2
Close
11 Jul
3
Allotment
-
4
Listing
16 Jul

About Asston Pharmaceuticals

Asston Pharmaceuticals is an SME operating in the pharmaceutical sector, likely focusing on manufacturing or distribution of specific drug formulations. The company's specific niche and product portfolio are crucial to understanding its competitive positioning.

Subscription Status

QIB
3.51x
NII
0.66x
Retail
1.22x
CategoryDay 3Day 2Day 1
QIB85.76x4.47x3.51x
NII353.14x19.67x0.66x
Retail172.06x16.66x1.22x
Total186.55x13.84x1.75x

Risk Factors

SME IPOs are inherently riskier than mainboard IPOs due to smaller size, potentially lower liquidity, and increased susceptibility to market fluctuations.
Dependence on regulatory approvals and compliance within the pharmaceutical industry poses significant risk. Changes in regulations can drastically impact operations and profitability.
The specific product portfolio of Asston Pharmaceuticals is unknown, rendering an assessment of competitive pressures difficult. Reliance on a limited number of products could create vulnerability.